[1]
|
A. Jemal, R. Siegel, E. Ward, et al., “Cancer Statistics, 2009,” CA: A Cancer Journal for Clinicians, Vol. 59, No. 4, 2009, pp. 225-249. doi:10.3322/caac.20006
|
[2]
|
J. Ferlay, H. R. Shin, F. Bray, et al., “Estimates of Worldwide Burden of Cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, Vol. 127, No. 12, 2010, pp. 2893-2917.doi:10.1002/ijc.25516
|
[3]
|
T. Iizasa, M. Suzuki, K. Yasufuku, et al., “Preoperative Pulmonary Function as a Prognostic Factor for Stage I Non-Small Cell Lung Carcinoma,” The Annals of Thoracic Surgery, Vol. 77, No. 6, 2004, pp. 1896-1902.
|
[4]
|
T. Win, A. Jackson, L. Sharples, et al., “Relationship between Pulmonary Function and Lung Cancer Surgical Outcome,” European Respiratory Journal, Vol. 25, No. 4, 2005, pp. 594-599. doi:10.1183/09031936.05.00077504
|
[5]
|
S. Raviv, K. A. Hawkins, M. M. DeCamp Jr., et al., “Lung Cancer in Chronic Obstructive Pulmonary Disease Enhancing Surgical Options and Outcomes,” American Journal of Respiratory and Critical Care Medicine, Vol. 183, No. 9, 2011, pp. 1138-1146.
doi:10.1164/rccm.201008-1274CI
|
[6]
|
K. Yoshimatsu, N. K. Altorki, D. Golijanin, et al., “Inducible Prostaglandin E Synthase is Overexpressed in Non-Small Cell Lung Cancer,” Clinical Cancer Research, Vol. 7, No. 9, 2001, pp. 2669-2674.
|
[7]
|
S. Margaritora, A. Cesario, G. Gusumano, et al., “Is Pulmonary Function Damaged by Neoadjuvant Lung Cancer Therapy? A Comprehensive Serial Time-Trend Analysis of Pulmonary Function after Induction Radiochemotherapy Plus Surgery,” The Journal of Thoracic and Cardiovascular Surgery, Vol. 139, No. 6, 2010, pp. 1457-1463.
doi:10.1016/j.jtcvs.2009.10.023
|
[8]
|
S. Takeda, Y. Funakoshi, Y. Kadota, et al., “Fall in Diffusing Capacity Associated with Induction Therapy for Lung Cancer: A Predictor of Postoperative Complication? The Annals of Thoracic Surgery, Vol. 82, No. 1, 2006, pp. 232-236. doi:10.1016/j.athoracsur.2006.01.045
|
[9]
|
S. Baser, V. R. Shannon, G. A. Eapen, et al., “Smoking Cessation after Diagnosis of Lung Cancer Is Associated with a Beneficial Effect on Performance Status,” Chest, Vol. 130, No. 6, 2006, pp. 1784-1790.
|
[10]
|
K. L. Tsai, E. Gupta and L. B. Haramati, “Pulmonary Atelectasis: A Frequent Alternative Diagnosis in Patients Undergoing CT-PA for Suspected Pulmonary Embolism,” Emergency Radiology, Vol. 10, No. 5, 2004, pp. 282-286. doi:10.1007/s10140-004-0328-5
|
[11]
|
A. G. Agustí, J. Cardús, J. Roca, et al., “Ventilation-Perfusion Mismatch in Patients with Pleural Effusion: Effects of Thoracentesis,” American Journal of Respiratory and Critical Care Medicine, Vol. 156, No. 4, 1997, pp. 1205-1209.
|
[12]
|
M. Reyhan, M. Aydin, A. Sukan, et al., “Ventilation-Perfusion Mismatch Secondary to Arterial Bullet Embolism,” Clinical Nuclear Medicine, Vol. 32, No. 4, 2007, pp. 330-332. doi:10.1097/01.rlu.0000256856.53656.b1
|
[13]
|
A. L. Cheville, A. M. Dose, J. R. Basford, et al., “Insights into the Reluctance of Patients with Late-Stage Cancer to Adopt Exercise as a Means to Reduce Their Symptoms and Improve Their Function,” Journal of Pain and Symptom Management, Vol. 44, No. 1, 2012, pp. 84-94.
doi:10.1016/j.jpainsymman.2011.08.009
|